Peptide record

TPDB11352

Cathelicidin CATH2 Cc-CATH2 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
32 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11352
Cathelicidin CATH2 Cc-CATH2
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP Peptipedia AFP-GFuse Antifungipept CAFPdb AVPpred-BWR ToxinPred 3.0 DBAASP
standard
No
A 32-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
LVQRGRFGRFLKKVRRFIPKVIIAAQIGSRFG
Physicochemical Analysis
C173H289N55O36
NDCEHMTWY
R
3715.54
13.10
9
0
15
+9
2.60
0.103
106.56
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
3
Residue Composition
number
2
A
6
R
0
N
0
D
0
C
0
E
2
Q
4
G
0
H
4
I
2
L
3
K
0
M
4
F
1
P
1
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 2 R: 6 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 4 H: 0 I: 4 L: 2 K: 3 M: 0 F: 4 P: 1 S: 1 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
32
C173H289N55O36
3715.54
13.10
+9
2.60
0.103
Evidence Records 64 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.3 µM

Target

Staphylococcus aureus ATCC 2592

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus
Evidence 2 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP

Other

ainst Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM
Evidence 3 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

Staphylococcus haemolyticus IS 2401 or DRa

Source & Reference

dbAMP

Other

92 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes
Evidence 4 Activity

Activity

MIC
Antibacterial
1.3 µM

Target

Enterococcus faecalis IS981

Source & Reference

dbAMP

Other

, S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A
Evidence 5 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

E. faecium IS 1299

Source & Reference

dbAMP

Other

. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or
Evidence 6 Activity

Activity

MIC
Antibacterial
1.3 µM

Target

P. acnes

Source & Reference

dbAMP

Other

C 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. b
Evidence 7 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

Klebsiella oxytoca

Source & Reference

dbAMP

Other

aecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM),
Evidence 8 Activity

Activity

MIC
Antibacterial
1.3 µM

Target

A. baumannii IS 2178 or Drb

Source & Reference

dbAMP

Other

um IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 2
Evidence 9 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

A. baumannii IS 2373

Source & Reference

dbAMP

Other

uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. c
Evidence 10 Activity

Activity

MIC
Antibacterial
0.6-1.3 µM

Target

Stenotrophomonas maltophilia

Source & Reference

dbAMP

Other

, A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-
Evidence 11 Activity

Activity

MIC
Antibacterial
1.3-5.1 µM

Target

Escherichia coli ATCC 27853 IS 1334-5

Source & Reference

dbAMP

Other

uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S.
Evidence 12 Activity

Activity

MIC
Antibacterial
10.1 µM

Target

P. vulgaris

Source & Reference

dbAMP

Other

E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C
Evidence 13 Activity

Activity

MIC
Antibacterial
5.1 µM

Target

S. typhi IS 1408

Source & Reference

dbAMP

Other

uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime m
Evidence 14 Activity

Activity

MIC
Antibacterial
1.3 µM

Target

Candida albicans ATCC 2002

Source & Reference

dbAMP

Other

.3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 15 Activity

Activity

MIC
Antibacterial
10.1 µM

Target

C. glabrata IS 0902

Source & Reference

dbAMP

Other

), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 16 Activity

Activity

MIC
Antifungal
0.3 µM

Target

Staphylococcus aureus ATCC 2592

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus
Evidence 17 Activity

Activity

MIC
Antifungal
2.5 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ainst Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM
Evidence 18 Activity

Activity

MIC
Antifungal
2.5 µM

Target

Staphylococcus haemolyticus IS 2401 or DRa

Source & Reference

dbAMP CAFPdb Antifungipept

Other

92 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes
Evidence 19 Activity

Activity

MIC
Antifungal
1.3 µM

Target

Enterococcus faecalis IS981

Source & Reference

dbAMP CAFPdb Antifungipept

Other

, S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A
Evidence 20 Activity

Activity

MIC
Antifungal
2.5 µM

Target

E. faecium IS 1299

Source & Reference

dbAMP CAFPdb Antifungipept

Other

. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or
Evidence 21 Activity

Activity

MIC
Antifungal
1.3 µM

Target

P. acnes

Source & Reference

dbAMP CAFPdb Antifungipept

Other

C 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. b
Evidence 22 Activity

Activity

MIC
Antifungal
2.5 µM

Target

Klebsiella oxytoca

Source & Reference

dbAMP CAFPdb Antifungipept

Other

aecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM),
Evidence 23 Activity

Activity

MIC
Antifungal
1.3 µM

Target

A. baumannii IS 2178 or Drb

Source & Reference

dbAMP CAFPdb Antifungipept

Other

um IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 2
Evidence 24 Activity

Activity

MIC
Antifungal
2.5 µM

Target

A. baumannii IS 2373

Source & Reference

dbAMP CAFPdb Antifungipept

Other

uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. c
Evidence 25 Activity

Activity

MIC
Antifungal
0.6-1.3 µM

Target

Stenotrophomonas maltophilia

Source & Reference

dbAMP CAFPdb Antifungipept

Other

, A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-
Evidence 26 Activity

Activity

MIC
Antifungal
1.3-5.1 µM

Target

Escherichia coli ATCC 27853 IS 1334-5

Source & Reference

dbAMP CAFPdb Antifungipept

Other

uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S.
Evidence 27 Activity

Activity

MIC
Antifungal
10.1 µM

Target

P. vulgaris

Source & Reference

dbAMP CAFPdb Antifungipept

Other

E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C
Evidence 28 Activity

Activity

MIC
Antifungal
5.1 µM

Target

S. typhi IS 1408

Source & Reference

dbAMP CAFPdb Antifungipept

Other

uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime m
Evidence 29 Activity

Activity

MIC
Antifungal
1.3 µM

Target

Candida albicans ATCC 2002

Source & Reference

dbAMP CAFPdb Antifungipept

Other

.3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 30 Activity

Activity

MIC
Antifungal
10.1 µM

Target

C. glabrata IS 0902

Source & Reference

dbAMP CAFPdb Antifungipept

Other

), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 31 Activity

Activity

MIC
Antiparasitic
0.3 µM

Target

Staphylococcus aureus ATCC 2592

Source & Reference

NA

Other

Active against Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus
Evidence 32 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

ainst Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM
Evidence 33 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

Staphylococcus haemolyticus IS 2401 or DRa

Source & Reference

NA

Other

92 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes
Evidence 34 Activity

Activity

MIC
Antiparasitic
1.3 µM

Target

Enterococcus faecalis IS981

Source & Reference

NA

Other

, S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A
Evidence 35 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

E. faecium IS 1299

Source & Reference

NA

Other

. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or
Evidence 36 Activity

Activity

MIC
Antiparasitic
1.3 µM

Target

P. acnes

Source & Reference

NA

Other

C 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. b
Evidence 37 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

Klebsiella oxytoca

Source & Reference

NA

Other

aecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM),
Evidence 38 Activity

Activity

MIC
Antiparasitic
1.3 µM

Target

A. baumannii IS 2178 or Drb

Source & Reference

NA

Other

um IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 2
Evidence 39 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

A. baumannii IS 2373

Source & Reference

NA

Other

uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. c
Evidence 40 Activity

Activity

MIC
Antiparasitic
0.6-1.3 µM

Target

Stenotrophomonas maltophilia

Source & Reference

NA

Other

, A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-
Evidence 41 Activity

Activity

MIC
Antiparasitic
1.3-5.1 µM

Target

Escherichia coli ATCC 27853 IS 1334-5

Source & Reference

NA

Other

uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S.
Evidence 42 Activity

Activity

MIC
Antiparasitic
10.1 µM

Target

P. vulgaris

Source & Reference

NA

Other

E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C
Evidence 43 Activity

Activity

MIC
Antiparasitic
5.1 µM

Target

S. typhi IS 1408

Source & Reference

NA

Other

uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime m
Evidence 44 Activity

Activity

MIC
Antiparasitic
1.3 µM

Target

Candida albicans ATCC 2002

Source & Reference

NA

Other

.3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 45 Activity

Activity

MIC
Antiparasitic
10.1 µM

Target

C. glabrata IS 0902

Source & Reference

NA

Other

), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 46 Activity

Activity

MIC
Antiviral
0.3 µM

Target

Staphylococcus aureus ATCC 2592

Source & Reference

NA

Other

Active against Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus
Evidence 47 Activity

Activity

MIC
Antiviral
2.5 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

ainst Gram+ S. aureus ATCC 2592 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM
Evidence 48 Activity

Activity

MIC
Antiviral
2.5 µM

Target

Staphylococcus haemolyticus IS 2401 or DRa

Source & Reference

NA

Other

92 (MIC 0.3 uM), clinical strains (MIC 20.2 uM or >26.9 uM), S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes
Evidence 49 Activity

Activity

MIC
Antiviral
1.3 µM

Target

Enterococcus faecalis IS981

Source & Reference

NA

Other

, S. epidermidis (MIC 2.5 uM), S. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A
Evidence 50 Activity

Activity

MIC
Antiviral
2.5 µM

Target

E. faecium IS 1299

Source & Reference

NA

Other

. haemolyticus IS 2401 or DRa (MIC 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or
Evidence 51 Activity

Activity

MIC
Antiviral
1.3 µM

Target

P. acnes

Source & Reference

NA

Other

C 2.5 uM), N. asteroids, E. faecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. b
Evidence 52 Activity

Activity

MIC
Antiviral
2.5 µM

Target

Klebsiella oxytoca

Source & Reference

NA

Other

aecalis IS981 (MIC 1.3 uM), E. faecium IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM),
Evidence 53 Activity

Activity

MIC
Antiviral
1.3 µM

Target

A. baumannii IS 2178 or Drb

Source & Reference

NA

Other

um IS 1299 (MIC 2.5 uM), P. acnes (MIC 1.3 uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 2
Evidence 54 Activity

Activity

MIC
Antiviral
2.5 µM

Target

A. baumannii IS 2373

Source & Reference

NA

Other

uM), Gram- K. oxytoca (MIC 2.5 uM), A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. c
Evidence 55 Activity

Activity

MIC
Antiviral
0.6-1.3 µM

Target

Stenotrophomonas maltophilia

Source & Reference

NA

Other

, A. sobria, A. baumannii IS 2178 or Drb (MIC 1.3 uM), A. baumannii IS 2373 (MIC 2.5 uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-
Evidence 56 Activity

Activity

MIC
Antiviral
1.3-5.1 µM

Target

Escherichia coli ATCC 27853 IS 1334-5

Source & Reference

NA

Other

uM), S. maltophilia (MIC 0.6-1.3 uM), P. aeruginosa ATCC 27853, IS 1411-3 (MIC 10.1 uM), E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S.
Evidence 57 Activity

Activity

MIC
Antiviral
10.1 µM

Target

P. vulgaris

Source & Reference

NA

Other

E. coli ATCC 27853 IS 1334-5(MIC 1.3-5.1 uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C
Evidence 58 Activity

Activity

MIC
Antiviral
5.1 µM

Target

S. typhi IS 1408

Source & Reference

NA

Other

uM), K. pneumoniae IS strains (MIC 1..3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime m
Evidence 59 Activity

Activity

MIC
Antiviral
1.3 µM

Target

Candida albicans ATCC 2002

Source & Reference

NA

Other

.3-5.1 uM), P. vulgaris (MIC 10.1 uM), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 60 Activity

Activity

MIC
Antiviral
10.1 µM

Target

C. glabrata IS 0902

Source & Reference

NA

Other

), P. mirabilis, S. typhi IS 1408 (MIC 5.1 uM), fungi C. albicans ATCC 2002 (MIC 1.3 uM), C. glabrata IS 0902 (MIC 10.1 uM), and slime mold (MIC 0.6 uM).
Evidence 61 Activity

Activity

0% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix. | FEBS J | 2011
Evidence 62 Activity

Activity

4% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
4% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix. | FEBS J | 2011
Evidence 63 Activity

Activity

IC50
Toxicity
75 µg/mL
Cytotoxic
IC50 | 75 | µg/mL | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix. | FEBS J | 2011
Evidence 64 Activity

Target

Cutibacterium acnes

Source & Reference

DBAASP